Giuliana Grossi

Study finds rural Appalachia faces soaring insomnia and sleep apnea, tied to poverty and stress, urging targeted, equity-focused sleep interventions.

Major health plans cut millions of preapproval hurdles, add 90-day continuity protections, and push real-time e-authorization to speed care access.

ACIP changes threaten vaccine coverage and raise costs, according to a roundtable of experts warning of widening disparities and long-term public health risks.

Global pediatric HIV data show dolutegravir links to early modest weight gain that plateaus by year 2, easing concerns and highlighting regional nutrition gaps.

From teledermatology billing to rural outreach and transplant advances, new studies and presentations reveal shifts in access, equity, and patient outcomes.

A global cohort has tracked pediatric HIV growth after dolutegravir, showing early catch-up weight gain, then stable BMI without long-term obesity risk.

Half of working-age Medicaid enrollees face disenrollment under national work requirements, despite having greater functional impairment than those who would comply.

Experts reflect on opioid policy impacts, IRA reforms and insulin caps impact drug access, and oncology leaders advance more equitable, integrated cancer care.

A new analysis projects that millions will lose Medicaid expansion coverage—including many who are working, exempt, or have serious health needs.

New studies show 2024 IRA Medicare drug caps and expanded subsidies cut cost-related nonadherence, especially for those with chronic disease.

Expert insights reveal how to spot inflammation in deeply pigmented skin and use new biologics and melasma therapies to reduce dyspigmentation.

Oncology has never had more to offer, and yet it is straining under the weight of its own progress.

New studies link extreme heat, obesity coaching gaps, cancer delays, ACA cost spikes, and income inequality to widening global health disparities.

Vaccine schedule shifts may widen gaps; learn how safety-net workflows and community education counter misinformation and boost uptake.

New studies link abortion bans to higher births and WIC demand and spotlight care-access gaps, cancer disparities, and value-based reforms shaping 2026.

Cost barriers push Latino adults to delay care, raising emergency department visits.

New research links post-Dobbs total abortion bans to higher births and WIC demand, raising safety-net costs and access concerns.

New data tracks young-onset colorectal cancer, Medicaid health gaps, pediatric diabetes spikes, and drug-pricing shifts reshaping US care in 2026 highlight this weekly roundup.

Experts unpacked MFN drug pricing, expired ACA subsidies, and IRA fallout for community oncology in a recent webinar.

Health inequities add $360 billion yearly; see how employers uncover disparities in claims, rethink deductibles, and invest in prevention to curb costs.

Employers and members can cut GLP-1 weight-loss costs with carve-outs, split payments, and transparent, updated price guides.

Meta-analysis links obstructive sleep apnea to early kidney injury markers, especially in severe OSA and hypertension, highlighting need for renal monitoring.

Survey flags GLP-1 cost hurdles as nurses win staffing protections, new trauma center cuts shooting deaths, and understaffing data sharpen care debates.

Scripta allows consumers to compare prescription prices, coupons, and insurance options in one place, helping patients and employers find affordable meds and smarter choices.

Employers use carve-outs and cash-pay channels to reduce GLP-1 costs, while Scripta’s Navigator helps members compare prices and find support.

New data show Chicago’s South Side Level 1 trauma center cuts gunshot travel times and lowers firearm deaths, highlighting equity gains.

New GLP-1 pills challenge injections as competition, and discussions of possible Medicare coverage could push prices down.

From clinic closures to gene therapy costs, new data reveal how policy, prices, and structural racism reshape US health access and outcomes.

Oral Wegovy reshapes GLP-1 costs: cash pay can be cheaper, insurance pricing often matches shots, and coverage hinges on employer benefits and coding.

Systematic review finds sleep disturbances in menopause are highly prevalent and linked to worse QOL, depression, pain, and reduced work productivity.